IPO Timeline Raw facts
Company Overview
| Stock Name | Fangzhou Jianke |
|---|---|
| Stock Code | 06086 |
| Company Full Name | Fangzhou Inc. |
| Industry | 醫療保健 |
| Principal Activities | 公司是是中國最大的在線慢病管理平臺,為不斷增長的慢病患者提供覆蓋整個疾病周期的定制醫療護理及精準醫療,目標為將覆蓋整個疾病周期的服務推廣至更廣泛的疾病領域。 |
| Listing Date | 2024-07-09 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國廣東省廣州市黃埔區蘿崗科學城科學大道99號科匯金谷S棟四街一至二樓 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://investors.jianke.com/ |
| Share Registrar | 香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited) |
| Registrar Contact | (852)2862 8628 |
| A-Share/US Dual Listing | No |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 8.18 / shares |
| Offer Price Range | Final offer price only, no range |
| Lot Size | 500 shares |
| Entry Threshold | HK$ 4,090 |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | 23,800,000 shares |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | Yes |
| Stabilizing Manager (Greenshoe) | Citigroup Global Markets Asia Limited CE AAA137 |
| Cornerstone Share | No cornerstone investors |
| Clawback Tiers | To be extracted |
| Reallocation Option | No |
| Total Global Offering Size | HK$ 194,684,000 |
Subscription Tiers
Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1 lots | 500 | HK$ 4,090 |
| 2 lots | 1,000 | HK$ 8,180 |
| 3 lots | 1,500 | HK$ 12,270 |
| 4 lots | 2,000 | HK$ 16,360 |
| 5 lots | 2,500 | HK$ 20,450 |
| 6 lots | 3,000 | HK$ 24,540 |
| 7 lots | 3,500 | HK$ 28,630 |
| 8 lots | 4,000 | HK$ 32,720 |
| 9 lots | 4,500 | HK$ 36,810 |
| 10 lots | 5,000 | HK$ 40,900 |
| 12 lots | 6,000 | HK$ 49,080 |
| 14 lots | 7,000 | HK$ 57,260 |
| 16 lots | 8,000 | HK$ 65,440 |
| 18 lots | 9,000 | HK$ 73,620 |
| 20 lots | 10,000 | HK$ 81,800 |
| 30 lots | 15,000 | HK$ 122,700 |
| 40 lots | 20,000 | HK$ 163,600 |
| 50 lots | 25,000 | HK$ 204,500 |
| 60 lots | 30,000 | HK$ 245,400 |
| 70 lots | 35,000 | HK$ 286,300 |
| 80 lots | 40,000 | HK$ 327,200 |
| 90 lots | 45,000 | HK$ 368,100 |
| 100 lots | 50,000 | HK$ 409,000 |
| 120 lots | 60,000 | HK$ 490,800 |
| 140 lots | 70,000 | HK$ 572,600 |
| 160 lots | 80,000 | HK$ 654,400 |
| 180 lots | 90,000 | HK$ 736,200 |
| 200 lots | 100,000 | HK$ 818,000 |
| 400 lots | 200,000 | HK$ 1,636,000 |
| 600 lots | 300,000 | HK$ 2,454,000 |
| 800 lots | 400,000 | HK$ 3,272,000 |
| 1,000 lots | 500,000 | HK$ 4,090,000 |
| 1,200 lots | 600,000 | HK$ 4,908,000 |
| Lots Subscribed | Shares Subscribed | Subscription Amount (HKD) |
|---|---|---|
| 1,400 lots | 700,000 | HK$ 5,726,000 |
| 2,380 lots | 1,190,000 | HK$ 9,734,200 |
Stock Connect Inclusion Analysis
| 26Q4 Regular Review | |
| Inclusion Pathway | Regular Path |
|---|---|
| HK Market Cap | HK$ 1.74B |
| Est. Threshold | HK$ 9.39B |
| Analysis Result | HK market cap below threshold, need +439% |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | RMB 146.32 million |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | ~66.8% |
| Total Pre-IPO Investment | To be extracted |
| First Day Close | HK$ 4.53 |
|---|---|
| First Day Open | HK$ 4.68 |
| First Day Change | -44.62% |
| First Day Volume | 9892000.0 |
| First Day Turnover | 46415800.0 |
| Use of Proceeds | 1、約67.4%或42.51百萬港元將于未來三至五年用于拓展業務;
2、約16.0%或10.09百萬港元將于未來五年用于研發活動;
3、約11.6%或7.32百萬港元將用于公司對在線慢性疾病管理行業價值鏈中的其他利益相關者的潛在投資和收購或戰略聯盟;
4、約5.0%或3.15百萬港元將用作公司的運營資金和一般公司用途。 |
Underwriting Syndicate
Cornerstone Investors
Directors & Management
| Position | Chinese name | English Name |
|---|---|---|
| Chairman | David McKee HAND | — |
| Company Secretary | 鄒宇鳴;伍秀薇 | — |
Major Shareholders
| Major Shareholders & Holdings | Crescent Point投資實體(32.64%);Fangrong Management Limited(19.81%);Celaeno Group Limited(13.89%) |
|---|
Market Sentiment
The IPO was 16.63 times oversubscribed, indicating moderate market enthusiasm. The overall hit rate of 63.81% suggests relatively broad allocations, typical for a less aggressively sought offering. Final pricing at HK$8.18 reflected stable demand without a clear signal of severe underpricing or overpricing. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)
Tier Analysis
The data reveals a classic inefficiency: the last A-tier applicant (HK$600,000) and the first B-tier applicant (HK$700,000) both received only 1 expected lot, making the additional HK$100,000 in the B-head subscription yield no marginal benefit. This dulls the incentive to cross into B-head territory and may reflect a poorly calibrated threshold. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)
Demographics
Demographic details such as mainland participation, gender, or regional distribution are not available in the provided data, precluding any analysis of applicant population trends. Without this information, no meaningful demographic conclusions can be drawn. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)




